News
As a result of the restructuring, Embecta expects pretax savings between $7 million and $8 million during the second half of ...
Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...
CEO Bryan Hanson said tariffs have given “a higher sense of urgency” to the company’s existing efforts to regionalize its ...
By Wednesday, the two countries will charge 10% baseline duties during the period and remove certain retaliatory levies that ...
Policies and actions reshaping the healthcare industry began pouring out of President Donald Trump’s White House nearly from ...
Medical device manufacturers could face increased costs if the Commerce Department's Section 232 probe leads to tariffs on ...
The company expects a tariff impact of up to 300 million euros, with the biggest hit from European goods going to the U.S.
The diabetes tech company raised its expectations for revenue and gross margins, despite the impact of tariffs.
The mass cuts, which included communications staff, could slow public notices on medical device recalls and other safety ...
Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA ...
The company plans to launch the lens, which supports vision at all distances, in Europe in the coming weeks.
Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results